Aytu BioPharma Set to Report Q4 2026 Earnings Monday

Seeking Alpha··US·Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Aytu BioPharma is scheduled to announce its Q4 earnings results on Monday, September 21st, after market close. The consensus EPS estimate is -$0.35, which represents an 88.1% improvement year over year. The consensus revenue estimate is $12.28M, a decline of 18.7% year over year.

Impact on assets 1

Health Care▲
Aytu BioScience Inc
AYTU
± MixedCapitalrelevance

Aytu is set to report Q4 earnings Monday with consensus EPS improving but revenue expected to decline 18.7% YoY.